Literature DB >> 2117189

Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy.

G Wuertemberger1, J Zielinsky, P Sliwinsky, C Auw-Haedrich, H Matthys.   

Abstract

Long-term oxygen therapy has proven increased survival rates of patients with severe chronic obstructive pulmonary lung disease and remains the only treatment so far to prolong life in these patients. No study has related hemodynamic measurements, lung function data, and age at beginning of long-term oxygen treatment to prognosis in these patients. In a retrospective study, we analyzed these parameters for 76 survivors and 51 deceased, starting supplemental oxygen therapy in 1981 and thereafter, concerning significant differences using the Proportional Hazards General Linear Model Procedure. A longer survival could be shown for PaP less than 30 mmHg when compared to PaP greater than 30 mmHg (p = 0.0442) and for the age less than 60 yrs compared to greater than 60 yrs (p = 0.0317). No contribution to prognosis could be made by FEV1, IVC, PaO2 and nationality. We conclude that hemodynamic measurements prior to long-term oxygen treatment are necessary since, besides age, they serve as the only indicator for prognosis in these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2117189     DOI: 10.1007/bf02718205

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  13 in total

1.  Prognosis in chronic obstructive pulmonary disease.

Authors:  S F Boushy; H K Thompson; L B North; A R Beale; T R Snow
Journal:  Am Rev Respir Dis       Date:  1973-12

2.  Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery.

Authors:  A S Abraham; R B Cole; I D Green; R B Hedworth-Whitty; S W Clarke; J M Bishop
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

Review 3.  State of the art: chronic cor pulmonale.

Authors:  A P Fishman
Journal:  Am Rev Respir Dis       Date:  1976-10

4.  Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease.

Authors:  E Weitzenblum; A Sautegeau; M Ehrhart; M Mammosser; C Hirth; E Roegel
Journal:  Am Rev Respir Dis       Date:  1984-12

5.  Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study.

Authors:  G A Traver; M G Cline; B Burrows
Journal:  Am Rev Respir Dis       Date:  1979-06

6.  Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party.

Authors: 
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

7.  Prognosis in severe chronic obstructive pulmonary disease.

Authors:  D S Postma; J Burema; F Gimeno; J F May; J M Smit; E J Steenhuis; L T Weele; H J Sluiter
Journal:  Am Rev Respir Dis       Date:  1979-03

8.  The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study.

Authors:  B Meyrick; L Reid
Journal:  Lab Invest       Date:  1978-02       Impact factor: 5.662

9.  Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale.

Authors:  K Ashutosh; G Mead; M Dunsky
Journal:  Am Rev Respir Dis       Date:  1983-04

10.  Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease.

Authors:  R M Timms; F U Khaja; G W Williams
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

View more
  2 in total

1.  Pulmonary hypertension in a stable community-based COPD population.

Authors:  Vadim Fayngersh; Fotios Drakopanagiotakis; F Dennis McCool; James R Klinger
Journal:  Lung       Date:  2011-08-04       Impact factor: 2.584

2.  Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease.

Authors:  Andrew C Stone; Jason T Machan; Jeffery Mazer; Brian Casserly; James R Klinger
Journal:  Lung       Date:  2011-05-10       Impact factor: 2.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.